Terns Pharmaceuticals, Inc.
TERN
Rang în acțiuni
#3584
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Preț acțiune
$52.95
Ultima sincronizare: 2026-05-15
Capitalizare de piață
$4.77B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
529.61%
Țară
US
Tranzacționează Terns Pharmaceuticals, Inc. (TERN)
Categorie
Healthcare
EPS pentru Terns Pharmaceuticals, Inc. (TERN)
EPS la data de December 2025 TTM: $-1.03
Conform celor mai recente rapoarte financiare și prețului acțiunilor Terns Pharmaceuticals, Inc., EPS-ul actual al companiei (TTM) este $-1.03. La sfârșitul anului 2023, compania avea un EPS de $-1.27 o scădere comparativ cu EPS-ului din 2022, care a fost de $-1.67.
Istoricul EPS pentru Terns Pharmaceuticals, Inc. din 2018 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-1.03 | -8.04% |
| 2024 | $-1.12 | -11.81% |
| 2023 | $-1.27 | -23.95% |
| 2022 | $-1.67 | -15.66% |
| 2021 | $-1.98 | 22.98% |
| 2020 | $-1.61 | -41.24% |
| 2019 | $-2.74 | 270.27% |
| 2018 | $-0.74 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | -1,781.55% |
US
|
|
| $-7.98 | 674.76% |
US
|
|
| $-5.29 | 413.59% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,793.20% |
NL
|
